A Cancer Genomics Scientist is a researcher who specializes in studying the genetic alterations that drive the development and progression of cancer. By analyzing the DNA, RNA, and epigenetic changes within tumor cells, these scientists seek to understand the molecular basis of different cancer types. Their work often involves using advanced technologies such as next-generation sequencing, bioinformatics, and computational biology to map cancer genomes and identify mutations, gene expression changes, and chromosomal abnormalities. This detailed genomic information helps uncover the mechanisms behind tumor growth, resistance to treatment, and metastasis. Cancer Genomics Scientists collaborate closely with clinicians to integrate genomic data into personalized treatment plans, enabling more precise and effective therapies tailored to an individual’s unique cancer profile.
Beyond their research efforts, Cancer Genomics Scientists play a vital role in the development of new diagnostic tools and targeted therapies. By identifying genetic markers and pathways involved in cancer, they contribute to the design of drugs that specifically target abnormal genes or proteins. They also participate in clinical trials, helping to translate genomic discoveries into practical treatments that improve patient outcomes. Their expertise bridges the gap between basic science and clinical application, driving the evolution of precision oncology. As the field of cancer genomics continues to expand, these scientists remain at the forefront, unlocking the genetic secrets of cancer to revolutionize diagnosis and therapy.
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China